☰

Marina Romero-Ramos, Ph.D. - Publications

Affiliations: 
Medical Biochemistry Aarhus University, Aarhus, Denmark 
Area:
Parkinson's disease
Website:
http://pure.au.dk/portal/en/persons/null%284d964ab5-ac0c-44fd-9ab0-4c4cffbdfb8c%29.html
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ferreira SA, Li C, Klæstrup IH, Vitic Z, Rasmussen RK, Kirkegaard A, Toft GU, Betzer C, Svendsen P, Jensen PH, Luo Y, Etzerodt A, Moestrup SK, Romero-Ramos M. Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson's disease. Npj Parkinson's Disease. 9: 164. PMID 38092806 DOI: 10.1038/s41531-023-00606-w  0.369
2023 Maimaitili M, Chen M, Febbraro F, Ucuncu E, Kelly R, Niclis JC, Christiansen JR, Mermet-Joret N, Niculescu D, Lauritsen J, Iannielli A, Klæstrup IH, Jensen UB, Qvist P, Nabavi S, ... ... Romero-Ramos M, et al. Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells. Nature Communications. 14: 7871. PMID 38052784 DOI: 10.1038/s41467-023-43471-0  0.765
2023 Lauritsen J, Romero-Ramos M. The systemic immune response in Parkinson's disease: focus on the peripheral immune component. Trends in Neurosciences. 46: 863-878. PMID 37598092 DOI: 10.1016/j.tins.2023.07.005  0.33
2023 Dzamko N, Romero-Ramos M, Thaler A. Editorial: Updates on inflammation in Parkinson's disease. Frontiers in Neurology. 14: 1138543. PMID 36741283 DOI: 10.3389/fneur.2023.1138543  0.31
2022 Konstantin Nissen S, Farmen K, Carstensen M, Schulte C, Goldeck D, Brockmann K, Romero-Ramos M. Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition. Brain, Behavior, and Immunity. PMID 35026420 DOI: 10.1016/j.bbi.2022.01.005  0.372
2021 Stokholm K, Thomsen MB, Phan JA, Møller LK, Bay-Richter C, Christiansen SH, Woldbye DPD, Romero-Ramos M, Landau AM. α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson's Disease. Biomedicines. 9. PMID 34944691 DOI: 10.3390/biomedicines9121876  0.33
2021 Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson's disease. Acta Neuropathologica. PMID 33555429 DOI: 10.1007/s00401-021-02268-5  0.37
2020 Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, Jensen PH, Brooks DJ, Landau AM, Romero-Ramos M. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease. 105229. PMID 33352233 DOI: 10.1016/j.nbd.2020.105229  0.402
2020 Nissen SK, Ferreira SA, Nielsen MC, Schulte C, Shrivastava K, Hennig D, Etzerodt A, Graversen JH, Berg D, Maetzler W, Panhelainen A, Møller HJ, Brockmann K, Romero-Ramos M. Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33332647 DOI: 10.1002/mds.28424  0.319
2020 Juul-Madsen K, Qvist P, Bendtsen KL, Langkilde AE, Vestergaard B, Howard KA, Dehesa-Etxebeste M, Paludan SR, Andersen GR, Jensen PH, Otzen DE, Romero-Ramos M, Vorup-Jensen T. Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4. Journal of Immunology (Baltimore, Md. : 1950). PMID 31969389 DOI: 10.4049/Jimmunol.1900494  0.375
2019 Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, Møller HJ, Maetzler W, Romero-Ramos M. Alterations in Blood Monocyte Functions in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31449711 DOI: 10.1002/mds.27815  0.31
2018 Tansey MG, Romero-Ramos M. Immune system responses in Parkinson's Disease: early and dynamic. The European Journal of Neuroscience. PMID 30474172 DOI: 10.1111/Ejn.14290  0.398
2018 Ferreira SA, Romero-Ramos M. Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention. Frontiers in Cellular Neuroscience. 12: 247. PMID 30127724 DOI: 10.3389/Fncel.2018.00247  0.527
2018 Olesen MN, Christiansen JR, Petersen SV, Jensen PH, Paslawski W, Romero-Ramos M, Sanchez-Guajardo V. CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon. 4: e00513. PMID 29560431 DOI: 10.1016/J.Heliyon.2018.E00513  0.76
2018 Refolo V, Bez F, Polissidis A, Kuzdas-Wood D, Sturm E, Kamaratou M, Poewe W, Stefanis L, Angela Cenci M, Romero-Ramos M, Wenning GK, Stefanova N. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathologica Communications. 6: 2. PMID 29298733 DOI: 10.1186/S40478-017-0504-Y  0.45
2017 Phan JA, Stokholm K, Zareba-Paslawska J, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Scientific Reports. 7: 6363. PMID 28743955 DOI: 10.1038/S41598-017-06724-9  0.44
2017 Jimenez-Ferrer I, Jewett M, Tontanahal A, Romero-Ramos M, Swanberg M. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Neurobiology of Disease. PMID 28736195 DOI: 10.1016/J.Nbd.2017.07.016  0.468
2016 Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, Bender D, Moestrup SK, Romero-Ramos M. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 9375-90. PMID 27605613 DOI: 10.1523/Jneurosci.1636-16.2016  0.429
2016 Christiansen JR, Olesen MN, Otzen DE, Romero-Ramos M, Sanchez-Guajardo V. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology. Journal of Neuroinflammation. 13: 74. PMID 27055651 DOI: 10.1186/S12974-016-0532-8  0.791
2016 Phan J, Stockholm K, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M. Alpha synuclein model of Parkinson's disease displays synaptic disruption Journal of Cerebral Blood Flow and Metabolism. 36. DOI: 10.1177/0271678X16639009  0.469
2015 Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience. PMID 25684748 DOI: 10.1016/J.Neuroscience.2015.02.008  0.821
2015 Delenclos M, Carrascal L, Jensen K, Romero-Ramos M. Corrigendum to “Immunolocalization of human alpha-synuclein in the Thy1-aSyn (“Line 61”) transgenic mouse line” [Neuroscience 277 (2014) 647–664] Neuroscience. 285: 356. DOI: 10.1016/J.Neuroscience.2014.11.006  0.75
2014 Delenclos M, Carrascal L, Jensen K, Romero-Ramos M. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line. Neuroscience. 277: 647-64. PMID 25090921 DOI: 10.1016/J.Neuroscience.2014.07.042  0.772
2014 Romero-Ramos M, von Euler Chelpin M, Sanchez-Guajardo V. Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Human Vaccines & Immunotherapeutics. 10: 852-67. PMID 24670306 DOI: 10.4161/Hv.28578  0.803
2014 Chelpin MVE, Romero-ramos M, Sanchez-guajardo V. Neuroprotective role of Regulatory T cells in Parkinson's disease: Effect of COP-1/alpha-synuclein vaccination on pathology progression Journal of Neuroimmunology. 275: 210. DOI: 10.1016/J.Jneuroim.2014.08.564  0.802
2014 Romero-ramos M, Christiansen J, Sanchez-guajardo V. Alpha-synuclein immunization, in the absence of alpha-synuclein over-expression or neural pathology, modifies microglia activation patterns and T cells' activation profiles Journal of Neuroimmunology. 275: 208-209. DOI: 10.1016/J.Jneuroim.2014.08.560  0.784
2014 Tentillier N, Etzerodt A, Olesen M, Rizalar FS, Moestrup SK, Romero-Ramos M. Anti-inflammatory therapy via CD163-macrophages in the 6-OHDA Parkinson's disease model Journal of Neuroimmunology. 275: 129. DOI: 10.1016/J.Jneuroim.2014.08.345  0.359
2013 Sanchez-Guajardo V, Annibali A, Jensen PH, Romero-Ramos M. α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. Journal of Neuropathology and Experimental Neurology. 72: 624-45. PMID 23771222 DOI: 10.1097/Nen.0B013E31829768D2  0.8
2013 Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D, Romero-Ramos M. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease. Neurobiology of Disease. 56: 47-58. PMID 23567651 DOI: 10.1016/J.Nbd.2013.03.014  0.816
2013 Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Experimental Neurology. 247: 45-58. PMID 23531432 DOI: 10.1016/J.Expneurol.2013.03.017  0.776
2013 Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. Asn Neuro. 5: 113-39. PMID 23506036 DOI: 10.1042/An20120066  0.792
2013 Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D, Romero-Ramos M. Corrigendum to "Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease" [Neurobiol. Dis. 56 (2013) 48-58] Neurobiology of Disease. 58: 191. DOI: 10.1016/J.Nbd.2013.06.003  0.81
2012 Febbraro F, Giorgi M, Caldarola S, Loreni F, Romero-Ramos M. α-Synuclein expression is modulated at the translational level by iron. Neuroreport. 23: 576-80. PMID 22581044 DOI: 10.1097/Wnr.0B013E328354A1F0  0.746
2012 Barkholt P, Sanchez-Guajardo V, Kirik D, Romero-Ramos M. Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates. Neuroscience. 208: 85-96. PMID 22342967 DOI: 10.1016/J.Neuroscience.2012.02.004  0.805
2011 Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease. Brain : a Journal of Neurology. 134: 2302-11. PMID 21712347 DOI: 10.1093/Brain/Awr149  0.808
2011 Bøttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K. Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. The Journal of Comparative Neurology. 519: 376-404. PMID 21165980 DOI: 10.1002/Cne.22524  0.398
2010 Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. The European Journal of Neuroscience. 32: 409-22. PMID 20704592 DOI: 10.1111/J.1460-9568.2010.07284.X  0.808
2010 Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. Plos One. 5: e8784. PMID 20098715 DOI: 10.1371/Journal.Pone.0008784  0.798
2009 Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schäfer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, Brandenburg LO, Deuschl G, Schreiber S, Kirik D, Lucius R. Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. International Journal of Immunopathology and Pharmacology. 22: 897-909. PMID 20074453  0.624
2007 Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, Kirik D. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain : a Journal of Neurology. 130: 799-815. PMID 17303591 DOI: 10.1093/Brain/Awl382  0.643
2006 Maingay M, Romero-Ramos M, Carta M, Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiology of Disease. 23: 522-32. PMID 16806952 DOI: 10.1016/J.Nbd.2006.04.007  0.741
2005 Mignon L, Vourc'h P, Romero-Ramos M, Osztermann P, Young HE, Lucas PA, Chesselet MF. Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats. The Journal of Comparative Neurology. 491: 96-108. PMID 16127692 DOI: 10.1002/Cne.20685  0.533
2005 Maingay M, Romero-Ramos M, Kirik D. Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease. Cns Spectrums. 10: 235-44. PMID 15744224 DOI: 10.1017/S1092852900010075  0.696
2004 Vourc'h P, Romero-Ramos M, Chivatakarn O, Young HE, Lucas PA, El-Kalay M, Chesselet MF. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochemical and Biophysical Research Communications. 317: 893-901. PMID 15081424 DOI: 10.1016/J.Bbrc.2004.03.121  0.559
2004 Young HE, Duplaa C, Romero-Ramos M, Chesselet MF, Vourc'h P, Yost MJ, Ericson K, Terracio L, Asahara T, Masuda H, Tamura-Ninomiya S, Detmer K, Bray RA, Steele TA, Hixson D, et al. Adult reserve stem cells and their potential for tissue engineering. Cell Biochemistry and Biophysics. 40: 1-80. PMID 14983110 DOI: 10.1385/Cbb:40:1:1  0.542
2003 Romero-Ramos M, Venero JL, Garcia-Rodriguez S, Ayala A, Machado A, Cano J. Semichronic inhibition of glutathione reductase promotes oxidative damage to proteins and induces both transcription and translation of tyrosine hydroxylase in the nigrostriatal system. Free Radical Research. 37: 1003-12. PMID 14670008 DOI: 10.1080/10715760310001598574  0.572
2002 Romero-Ramos M, Vourc'h P, Young HE, Lucas PA, Wu Y, Chivatakarn O, Zaman R, Dunkelman N, el-Kalay MA, Chesselet MF. Neuronal differentiation of stem cells isolated from adult muscle. Journal of Neuroscience Research. 69: 894-907. PMID 12205682 DOI: 10.1002/Jnr.10374  0.534
2000 Romero-Ramos M, Venero JL, Cano J, Machado A. Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat. Brain Research. Molecular Brain Research. 84: 7-16. PMID 11113527 DOI: 10.1016/S0169-328X(00)00171-6  0.577
2000 Romero-Ramos M, Venero JL, Santiago M, Rodriguez-Gómez JA, Vizuete ML, Cano J, Machado A. Decreased messenger RNA expression of key markers of the nigrostriatal dopaminergic system following vitamin E deficiency in the rat. Neuroscience. 101: 1029-36. PMID 11113352 DOI: 10.1016/S0306-4522(00)00424-3  0.556
1997 Rodríguez-Gómez JA, Romero-Ramos M, Vizuete ML, Venero JL, Cano J, Machado A. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine. Molecular Pharmacology. 52: 641-7. PMID 9380027 DOI: 10.1124/Mol.52.4.641  0.603
1997 Romero-Ramos M, Rodríguez-Gómez JA, Venero JL, Cano J, Machado A. Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. Free Radical Biology & Medicine. 23: 1-7. PMID 9165291 DOI: 10.1016/S0891-5849(96)00405-4  0.555
1997 Revuelta M, Romero-Ramos M, Venero JL, Millan F, Machado A, Cano J. Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet. Neuroscience. 77: 167-74. PMID 9044384 DOI: 10.1016/S0306-4522(96)00491-5  0.565
1995 Venero JL, Romero-Ramos M, Revuelta M, Machado A, Cano J. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system. Brain Research. 672: 153-8. PMID 7749737 DOI: 10.1016/0006-8993(94)01368-R  0.584
Show low-probability matches.